December 22 (SeeNews) - Serbian drug maker Hemofarm, a unit of Germany's Stada, launched a new production line at its plant in Sabac, in western Serbia, worth 10 million euro ($10.6 million), it said.
Hemofarm is expanding its portfolio by investing in the reconstruction of an old blister pack department and procuring new production equipment for five new production lines, the company said in a press release on Wednesday.
After the reconstruction is completed, the plant's production capacity will expand by 30 million to 37 million liquid form packs annually.
"This investment will further strengthen the leadership position of Stada, not only in the local and regional markets where Hemofarm operates, but also in other markets around the world," said Jesus Corchero Romero, senior vice-president of Stada Group for global operations.
($ = 0.9400 euro)